Target intelligence / Profile preview

Alpha-synuclein mRNA iron-responsive element (SNCA mRNA IRE)

Target
SNCA mRNA IRE
Molecular classification
RNA, Cis-regulatory element, Iron-responsive element
01

Overview

The Alpha-synuclein mRNA iron-responsive element (IRE) is a conserved stem-loop structure located within the 5' untranslated region (UTR) of the SNCA gene transcript (Rogers et al., 2011). This regulatory element functions as a sensor for cellular iron levels, binding to iron regulatory proteins (IRPs) to modulate the translation of alpha-synuclein protein (Friedlich et al., 2007). In conditions of high iron, IRPs dissociate from the IRE, allowing for increased translation, whereas low iron levels promote IRP binding and translational repression. Because the accumulation and aggregation of alpha-synuclein are central to the pathogenesis of Parkinson's disease and other synucleinopathies, this mRNA structure has emerged as a novel therapeutic target. Small molecules like buntanetap (Posiphen) are designed to stabilize the IRE-IRP complex or otherwise interfere with translation at this site to reduce the overall burden of alpha-synuclein (Annovis Bio, 2023). By targeting the production of the protein at the translational level, these therapies aim to slow or halt neurodegeneration.

Other names
SNCA 5'-UTR IREAlpha-synuclein 5'-untranslated region iron-responsive elementSNCA IREAlpha-synuclein mRNA 5'-UTR
02

Mechanism of action

Small molecule binding to the 5'-UTR IRE of SNCA mRNA to inhibit translation and reduce alpha-synuclein protein levels.

03

Biological functions

Translation regulationIron homeostasisProtein synthesis control
04

Disease associations

Parkinson's diseaseDementia with Lewy bodiesMultiple system atrophyNeurodegenerative disease
05

Safety considerations

Off-target effects on other IRE-containing mRNAs such as Ferritin or Amyloid precursor proteinSystemic iron metabolism disruptionPotential for unintended translational repression of essential proteins
06

Interacting drugs

Buntanetap

3 more in the full profile.

07

Biomarkers

Alpha-synuclein levels in cerebrospinal fluidAlpha-synuclein levels in plasmaIron levels in brain tissue

Beyond the preview

Go deeper on Alpha-synuclein mRNA iron-responsive element (SNCA mRNA IRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-synuclein mRNA iron-responsive element (SNCA mRNA IRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call